Search results for "Development"

showing 10 items of 26949 documents

Defective Induction of COX-2 Expression by Psoriatic Fibroblasts Promotes Pro-inflammatory Activation of Macrophages

2019

Fibroblasts play an important role as members of the innate immune system through the secretion of COX-2-derived inflammatory mediators such as prostaglandin E-2 (PGE(2)). However, it has been described that dermal fibroblasts behave like mesenchymal stem cells reducing lymphocyte recruitment and dendritic cell activation through PGE(2) release. As the role of fibroblasts in psoriasis remains poorly characterized, in the present study we have evaluated the possible influence of PGE(2) derived from dermal fibroblasts as modulator of the immune response in psoriatic skin. Our results indicate that under inflammatory conditions, psoriatic fibroblasts showed defective induction of COX-2, which …

lcsh:Immunologic diseases. AllergyAdultMale0301 basic medicineTHP-1 CellsLymphocyteImmunologyInflammationDinoprostoneYoung Adult03 medical and health sciences0302 clinical medicineImmune systemPsoriasismedicineHumansImmunology and AllergyPsoriasisProstaglandin E2SkinOriginal ResearchInflammationInnate immune systemChemistryMacrophagesMesenchymal stem cellpsoriasisDendritic cellMiddle AgedFibroblastsmedicine.diseaseCyclooxygenasecyclooxygenase030104 developmental biologymedicine.anatomical_structureCyclooxygenase 2inflammationCancer researchFemalemedicine.symptomlcsh:RC581-607030215 immunologymedicine.drug
researchProduct

Alzheimer's disease: new diagnostic and therapeutic tools.

2008

Abstract On March 19, 2008 a Symposium on Pathophysiology of Ageing and Age-Related diseases was held in Palermo, Italy. Here, the lectures of M. Racchi on History and future perspectives of Alzheimer Biomarkers and of G. Scapagnini on Cellular Stress Response and Brain Ageing are summarized. Alzheimer's disease (AD) is a heterogeneous and progressive neurodegenerative disease, which in Western society mainly accounts for clinica dementia. AD prevention is an important goal of ongoing research. Two objectives must be accomplished to make prevention feasible: i) individuals at high risk of AD need to be identified before the earliest symptoms become evident, by which time extensive neurodege…

lcsh:Immunologic diseases. AllergyAgingmedicine.medical_specialtyImmunologyShort ReportCellular homeostasisDiseaselcsh:Geriatrics03 medical and health sciences0302 clinical medicineEffective interventionsIntervention (counseling)Cellular stress responsemedicineDementiaIntensive care medicine030304 developmental biologyalzheimer ageing inflammation0303 health sciencesbusiness.industryNeurodegenerationmedicine.disease3. Good healthlcsh:RC952-954.6AgeingAgeingImmunologybusinesslcsh:RC581-607030217 neurology & neurosurgeryImmunityageing : IA
researchProduct

Heat-Shock Proteins in Autoimmunity

2013

Heat shock proteins (HSPs), also known as “stress proteins,” are among the highly conserved and immunogenic proteins shared among diverse groups of microbial agents and mammals [1]. Heat and other types of stressful stimuli can increase the cellular expression of HSPs. These proteins have been categorized into different families according to their molecular mass, for example, HSP110, HSP90, HSP70, HSP60, HSP40, HSP20-30, and HSP10 [1–3]. For uniformity, guidelines for the nomenclature of various human HSP families have been proposed [4]. Under physiological conditions, the ubiquitously distributed HSPs maintain the integrity and function of other cellular proteins in stressful conditions. H…

lcsh:Immunologic diseases. AllergyArticle SubjectImmunologychemical and pharmacologic phenomenaBiologymedicine.disease_causeAutoimmunity03 medical and health sciences0302 clinical medicineImmune systemImmunology and Microbiology (miscellaneous)Heat shock proteinmedicineImmunology and Allergy030304 developmental biology0303 health sciencesInnate immune systemFOXP3Acquired immune system3. Good healthMolecular mimicryEditorialImmunologyHSP60lcsh:RC581-607030217 neurology & neurosurgeryAutoimmune Diseases
researchProduct

IL-12 Expands and Differentiates Human Vγ2Vδ2 T Effector Cells Producing Antimicrobial Cytokines and Inhibiting Intracellular Mycobacterial Growth

2019

While IL-12 plays a key role in differentiation of protective CD4+ Th1 response, little is known about mechanisms whereby IL-12 differentiates other T-cell populations. Published studies suggest that predominant Vγ2Vδ2 T cells in humans/nonhuman primates (NHP) are a fast-acting T-cell subset, with capacities to rapidly expand and produce Th1 and cytotoxic cytokines in response to phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP) produced by Mycobacterium tuberculosis (Mtb) or others. However, whether IL-12 signaling pathway mediates fast-acting and Th1 or anti-microbial features of Vγ2Vδ2 T cells remains poorly defined. Here, we show that IL-12, but not other IL-12 fami…

lcsh:Immunologic diseases. AllergyCells1.1 Normal biological development and functioningproliferationImmunologyLymphocyte ActivationV gamma 2V delta 2 T cellsVaccine Related03 medical and health sciencesPhosphatidylinositol 3-Kinases0302 clinical medicineRare DiseasesUnderpinning researchT-Lymphocyte SubsetsImmunology and AllergyTuberculosis2.1 Biological and endogenous factorsHumansAetiologyIntraepithelial LymphocytesCells Cultured030304 developmental biologyOriginal Researchanti-tuberculosis0303 health sciencesCulturedVγ2Vδ2 T cellsTumor Necrosis Factor-alphaInflammatory and immune systemCorrectionCell DifferentiationMycobacterium tuberculosisdifferentiationSTAT4 Transcription FactorTh1 CellsInterleukin-12Organophosphates3. Good healthInfectious DiseasesGood Health and Well BeingMedical MicrobiologyIL-12Infectionlcsh:RC581-607Proto-Oncogene Proteins c-akt030215 immunologySignal TransductionFrontiers in Immunology
researchProduct

Role of Peripheral Immune Cells-Mediated Inflammation on the Process of Neurodegenerative Diseases

2020

Neurodegenerative diseases are characterized by progressive loss of selectively vulnerable neuronal populations, which contrasts with selectively static loss of neurons due to toxic or metabolic disorders. The mechanisms underlying their progressive nature remain unknown. To date, a timely and well-controlled peripheral inflammatory reaction is verified to be essential for neurodegenerative diseases remission. The influence of peripheral inflammation on the central nervous system is closely related to immune cells activation in peripheral blood. The immune cells activation participated in the uncontrolled and prolonged inflammation that drives the chronic progression of neurodegenerative di…

lcsh:Immunologic diseases. AllergyCentral Nervous System0301 basic medicinedendritic cellT-LymphocytesT cellImmunologyCentral nervous systemInflammationReviewmacrophageNatural killer cell03 medical and health sciences0302 clinical medicineImmune systemAnimalsHumansImmunology and AllergyMedicineMacrophageB cellInflammationB-LymphocytesB cellbusiness.industryMacrophagesT cellNeurodegenerative DiseasesDendritic cellnatural killer cellKiller Cells Natural030104 developmental biologymedicine.anatomical_structuremonocyteImmunologyNeurogenic Inflammationmedicine.symptomlcsh:RC581-607peripheral immune cellsbusiness030215 immunologyFrontiers in Immunology
researchProduct

Report from the second cytomegalovirus and immunosenescence workshop

2011

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.; International audience; The Second International Workshop on CMV & Immunosenescence was held in Cambridge, UK, 2-4th December, 2010. The presentations covered four separate sessions: cytomegalovirus and T cell phenotypes; T cell memory frequency, inflation and immunosenescence; cytomegalovirus in aging, mortality and disease states; and the immunobiology of cytomegalovirus-specific T cells and effects of the virus on vacc…

lcsh:Immunologic diseases. AllergyGerontologyAging[SDV.IMM] Life Sciences [q-bio]/Immunology[SDV]Life Sciences [q-bio]ImmunologyCongenital cytomegalovirus infectionDiseaseAgeing CMV immunitylcsh:Geriatrics0601 Biochemistry and Cell BiologyVaccine Related03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingMedicinecytomegalovirusComputingMilieux_MISCELLANEOUS030304 developmental biologyimmunosenescence0303 health sciencesbusiness.industryGeriatrics gerontologyImmunosenescencemedicine.disease3. Good healthlcsh:RC952-954.6AgeingHCMV InfectionInfectious DiseasesCommentary/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being[SDV.IMM]Life Sciences [q-bio]/ImmunologyImmunizationlcsh:RC581-607business030215 immunology
researchProduct

Interleukin 10 restores lipopolysaccharide-induced alterations in synaptic plasticity probed by repetitive magnetic stimulation

2020

Systemic inflammation is associated with alterations in complex brain functions such as learning and memory. However, diagnostic approaches to functionally assess and quantify inflammation-associated alterations in synaptic plasticity are not well-established. In previous work, we demonstrated that bacterial lipopolysaccharide (LPS)-induced systemic inflammation alters the ability of hippocampal neurons to express synaptic plasticity, i.e., the long-term potentiation (LTP) of excitatory neurotransmission. Here, we tested whether synaptic plasticity induced by repetitive magnetic stimulation (rMS), a non-invasive brain stimulation technique used in clinical practice, is affected by LPS-induc…

lcsh:Immunologic diseases. AllergyLipopolysaccharides0301 basic medicinenon-invasive brain stimulationInterleukin-1betaImmunologyTNFα-reporter mouseMice TransgenicStimulationNeurotransmissionHippocampusSynaptic TransmissionneuroinflammationInterferon-gammaMice03 medical and health sciences0302 clinical medicineGenes Reportertranscranial magnetic stimulationAnimalsImmunology and Allergyddc:610NeuroinflammationOriginal ResearchInflammationNeuronsNeuronal Plasticitysynaptic plasticityInterleukin-6Tumor Necrosis Factor-alphaChemistryLong-term potentiationInterleukin-10Mice Inbred C57BLOrganoids030104 developmental biologyBrain stimulationSynaptic plasticityExcitatory postsynaptic potentialTumor necrosis factor alphaMicrogliainterleukin 10lcsh:RC581-607Neuroscience030217 neurology & neurosurgery
researchProduct

eIF2α confers cellular tolerance to S. aureus α-toxin

2015

We report on the role of conserved stress-response pathways for cellular tolerance to a pore forming toxin. First, we observed that small molecular weight inhibitors including of eIF2α-phosphatase, jun-N-terminal kinase (JNK), and PI3-kinase sensitized normal mouse embryonal fibroblasts (MEFs) to the small pore forming S. aureus α-toxin. Sensitization depended on expression of mADAM10, the murine ortholog of a proposed high-affinity receptor for α-toxin in human cells. Similarly, eIF2α (S51A/S51A) MEFs, which harbor an Ala knock-in mutation at the regulated Ser51 phosphorylation site of eukaryotic translation initiation factor 2α, were hyper-sensitive to α-toxin. Inhibition of translation w…

lcsh:Immunologic diseases. AllergyMAPK/ERK pathwayImmunologyeIF2αBiologyCycloheximide03 medical and health scienceschemistry.chemical_compoundCellular toleranceImmunology and AllergyInitiation factorpore forming toxinsReceptorOriginal Research030304 developmental biologyGenetics0303 health sciencesKinase030302 biochemistry & molecular biologyJNK Mitogen-Activated Protein KinasesADAM10Translation (biology)MAPKCell biologyEIF2AK4chemistryPhosphorylationCytolysinS. aureus α-toxinlcsh:RC581-607Frontiers in Immunology
researchProduct

Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis

2014

With 1.4 million deaths and 8.7 million new cases in 2011, tuberculosis (TB) remains a global health care problem and together with HIV and Malaria represents one of the three infectious diseases world-wide. Control of the global TB epidemic has been impaired by the lack of an effective vaccine, by the emergence of drug-resistant forms of Mycobacterium tuberculosis (Mtb) and by the lack of sensitive and rapid diagnostics. It is estimated, by epidemiological reports, that one third of the world's population is latently infected with Mtb, but the majority of infected individuals develop long-lived protective immunity, which controls and contains Mtb in a T cell-dependent manner. Development o…

lcsh:Immunologic diseases. AllergyTuberculosisPopulationImmunologyReview ArticleDiseaseMycobacterium tuberculosis03 medical and health sciences0302 clinical medicineImmunitymedicineM. tuberculosiscytokineinfection.Immunology and AllergyCytotoxic T celleducationImmunodeficiency030304 developmental biologySettore MED/04 - Patologia Generale0303 health scienceseducation.field_of_studydiseasebiologybusiness.industrymedicine.diseasebiology.organism_classificationVirologyinfection3. Good healthhuman memory T cellsImmunologyCytokinesbusinesslcsh:RC581-607human memory T cellMalaria030215 immunologyM. tuberculosi
researchProduct

Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development

2012

Advanced therapy medicinal products (ATMPs), including cell therapy products, form a new class of medicines in the European Union. Since the ATMPs are at the forefront of scientific innovation in medicine, specific regulatory framework has been developed for these medicines and implemented from 2009. The Committee for Advanced Therapies (CAT) has been established at the European Medicines Agency (EMA) for centralized classification, certification and evaluation procedures, and other ATMP-related tasks. Guidance documents, initiatives, and interaction platforms are available to make the new framework more accessible for small- and medium-sized enterprises, academia, hospitals, and foundation…

lcsh:Immunologic diseases. Allergymesenchymal stem/progenitor cellMesenchymal stem cells (MSC)ImmunologyReview ArticleCertificationBest interestsAgency (sociology)Hospital Exemption authorisationImmunology and AllergyMedicinemedia_common.cataloged_instanceProduct (category theory)European unionHospital Exemptionmedia_commonbusiness.industrynational competent authorityCommittee for Advanced TherapiesCell therapy medicinal product (CTMP)AuthorizationGuidance documentsCommittee for Advanced Therapies (CAT)Engineering managementNew product developmentadvanced therapy medicinal productlcsh:RC581-607businesscell therapy medicinal productAdvanced therapy medicinal product (ATMP)Frontiers in Immunology
researchProduct